[Form 4] Thermo Fisher Scientific, Inc. Insider Trading Activity
Frederick M. Lowery, Executive Vice President of Thermo Fisher Scientific (TMO), reported multiple disposals of common stock on 08/28/2025 at a price of $489.74 per share. The Form 4 shows four separate disposition entries totaling 667.718 shares disposed (175.028 + 187.116 + 186.632 + 118.942) and remaining direct beneficial ownership reported in fractional amounts (14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724 across lines). The filing also reports indirect holdings of 1,174.88 shares through a 401(k) plan and 5.036 shares via a limited liability company, with a disclaimer of beneficial ownership for the LLC position.
Frederick M. Lowery, Executive Vice President di Thermo Fisher Scientific (TMO), ha effettuato diverse cessioni di azioni ordinarie il 28/08/2025 al prezzo di 489,74 USD per azione. Il modulo Form 4 riporta quattro operazioni distinte per un totale di 667,718 azioni cedute (175,028 + 187,116 + 186,632 + 118,942) e la titolarità diretta residua indicata in valori frazionari (14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724 sulle varie righe). La dichiarazione segnala inoltre partecipazioni indirette per 1,174.88 azioni tramite un piano 401(k) e 5.036 azioni attraverso una società a responsabilità limitata, specificando una rinuncia alla titolarità effettiva per la posizione nella LLC.
Frederick M. Lowery, vicepresidente ejecutivo de Thermo Fisher Scientific (TMO), reportó múltiples disposiciones de acciones ordinarias el 28/08/2025 a un precio de 489,74 USD por acción. El Formulario 4 muestra cuatro entradas de disposición separadas que suman 667,718 acciones desinvertidas (175,028 + 187,116 + 186,632 + 118,942) y la propiedad directa restante informada en cantidades fraccionarias (14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724 en las distintas líneas). La presentación también informa participaciones indirectas de 1,174.88 acciones a través de un plan 401(k) y 5.036 acciones vía una sociedad de responsabilidad limitada, con una renuncia de propiedad beneficiaria sobre la posición en la LLC.
Frederick M. Lowery, Thermo Fisher Scientific(TMO) 전무이사는 2025-08-28에 보통주를 주당 489.74달러에 여러 차례 처분했습니다. Form 4에는 각각 175.028, 187.116, 186.632, 118.942주로 총 667.718주를 처분한 네 건의 별도 처분 항목과, 각 항목별로 잔여 직접 보유 주식이 소수점 단위로 보고되어 있습니다(14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724). 제출서에는 또한 401(k) 계획을 통한 간접 보유 1,174.88주와 유한책임회사(LLC)를 통한 5.036주의 간접 보유가 기재되어 있으며, LLC 지분에 대해서는 수익적 소유권을 부인하고 있습니다.
Frederick M. Lowery, vice-président exécutif de Thermo Fisher Scientific (TMO), a réalisé plusieurs cessions d'actions ordinaires le 28/08/2025 au prix de 489,74 USD par action. Le formulaire 4 indique quatre écritures de cession distinctes totalisant 667,718 actions cédées (175,028 + 187,116 + 186,632 + 118,942) et la détention directe restante signalée en montants fractionnaires (14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724 selon les lignes). Le dépôt signale également des participations indirectes de 1,174.88 actions via un plan 401(k) et de 5.036 actions via une société à responsabilité limitée, avec une déclinaison de propriété bénéficiaire pour la position détenue par la LLC.
Frederick M. Lowery, Executive Vice President von Thermo Fisher Scientific (TMO), meldete mehrere Veräußerungen von Stammaktien am 28.08.2025 zu einem Kurs von 489,74 USD je Aktie. Das Formular 4 weist vier separate Veräußerungsposten aus, die insgesamt 667,718 veräußerte Aktien ergeben (175,028 + 187,116 + 186,632 + 118,942), und den verbleibenden direkten Besitz in Bruchteilen (14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724 in den jeweiligen Zeilen). Die Meldung nennt außerdem indirekte Beteiligungen von 1,174.88 Aktien über einen 401(k)-Plan und 5.036 Aktien über eine Limited Liability Company, wobei für die LLC-Position das wirtschaftliche Eigentum verneint wird.
- Continued equity ownership shown via a TMO 401(k) holding of 1,174.88 shares
- Disclosure of indirect ownership through a limited liability company (5.036 shares) with a clear disclaimer
- Insider disposed of 667.718 shares across four reported transactions on 08/28/2025
- Multiple disposal entries reduced direct share counts as shown by the reported post-transaction ownership lines
Insights
TL;DR: Multiple insider stock dispositions occurred on 08/28/2025 at $489.74, while the reporting person retains both direct and indirect holdings.
The report documents four discrete disposition transactions totaling 667.718 shares sold at $489.74 each. Post-transaction direct ownership is recorded on multiple lines as fractional share totals. Additionally, 1,174.88 shares are held in a TMO 401(k) and 5.036 shares are held indirectly via an LLC, with a disclaimer of beneficial ownership for the LLC stake. From an investor-data perspective, these are standard insider liquidity transactions without accompanying company operational or financial metrics in the filing.
TL;DR: The Form 4 discloses routine insider dispositions and stated indirect holdings; no governance events or role changes are reported.
The form indicates the reporting person is an Executive Vice President and lists multiple dispositions executed the same day under transaction code F. The filing clarifies indirect ownership categories (401(k) and an LLC) and includes a standard disclaimer regarding the LLC interest. There are no amendments, officer title changes, or joint filers noted. This disclosure meets Section 16 reporting requirements but does not signal governance actions.
Frederick M. Lowery, Executive Vice President di Thermo Fisher Scientific (TMO), ha effettuato diverse cessioni di azioni ordinarie il 28/08/2025 al prezzo di 489,74 USD per azione. Il modulo Form 4 riporta quattro operazioni distinte per un totale di 667,718 azioni cedute (175,028 + 187,116 + 186,632 + 118,942) e la titolarità diretta residua indicata in valori frazionari (14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724 sulle varie righe). La dichiarazione segnala inoltre partecipazioni indirette per 1,174.88 azioni tramite un piano 401(k) e 5.036 azioni attraverso una società a responsabilità limitata, specificando una rinuncia alla titolarità effettiva per la posizione nella LLC.
Frederick M. Lowery, vicepresidente ejecutivo de Thermo Fisher Scientific (TMO), reportó múltiples disposiciones de acciones ordinarias el 28/08/2025 a un precio de 489,74 USD por acción. El Formulario 4 muestra cuatro entradas de disposición separadas que suman 667,718 acciones desinvertidas (175,028 + 187,116 + 186,632 + 118,942) y la propiedad directa restante informada en cantidades fraccionarias (14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724 en las distintas líneas). La presentación también informa participaciones indirectas de 1,174.88 acciones a través de un plan 401(k) y 5.036 acciones vía una sociedad de responsabilidad limitada, con una renuncia de propiedad beneficiaria sobre la posición en la LLC.
Frederick M. Lowery, Thermo Fisher Scientific(TMO) 전무이사는 2025-08-28에 보통주를 주당 489.74달러에 여러 차례 처분했습니다. Form 4에는 각각 175.028, 187.116, 186.632, 118.942주로 총 667.718주를 처분한 네 건의 별도 처분 항목과, 각 항목별로 잔여 직접 보유 주식이 소수점 단위로 보고되어 있습니다(14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724). 제출서에는 또한 401(k) 계획을 통한 간접 보유 1,174.88주와 유한책임회사(LLC)를 통한 5.036주의 간접 보유가 기재되어 있으며, LLC 지분에 대해서는 수익적 소유권을 부인하고 있습니다.
Frederick M. Lowery, vice-président exécutif de Thermo Fisher Scientific (TMO), a réalisé plusieurs cessions d'actions ordinaires le 28/08/2025 au prix de 489,74 USD par action. Le formulaire 4 indique quatre écritures de cession distinctes totalisant 667,718 actions cédées (175,028 + 187,116 + 186,632 + 118,942) et la détention directe restante signalée en montants fractionnaires (14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724 selon les lignes). Le dépôt signale également des participations indirectes de 1,174.88 actions via un plan 401(k) et de 5.036 actions via une société à responsabilité limitée, avec une déclinaison de propriété bénéficiaire pour la position détenue par la LLC.
Frederick M. Lowery, Executive Vice President von Thermo Fisher Scientific (TMO), meldete mehrere Veräußerungen von Stammaktien am 28.08.2025 zu einem Kurs von 489,74 USD je Aktie. Das Formular 4 weist vier separate Veräußerungsposten aus, die insgesamt 667,718 veräußerte Aktien ergeben (175,028 + 187,116 + 186,632 + 118,942), und den verbleibenden direkten Besitz in Bruchteilen (14,860.0624; 14,672.9464; 14,486.3144; 14,367.3724 in den jeweiligen Zeilen). Die Meldung nennt außerdem indirekte Beteiligungen von 1,174.88 Aktien über einen 401(k)-Plan und 5.036 Aktien über eine Limited Liability Company, wobei für die LLC-Position das wirtschaftliche Eigentum verneint wird.